Delivery Order SPE2DB20D9214-SPE2DB24FD4VP

Award Date 8/2/24
Potential Completion Date 8/23/24
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,642.68 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with an ultimate completion date of October 4, 2024. The award is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
This federal contract award, valued at $17,121.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order to provide the DLA with PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,364.16 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a completion date of August 20, 2024. The award is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,920.50, is a firm fixed-price delivery order for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The contract is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,755.20 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,055.48 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,820.00 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a completion date of October 17, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,088.00 firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $22,425.70, is a firm fixed-price delivery order for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price valued at $17,771.40 and has an ultimate completion date of May 19, 2025. The contract is for the provision of 4,568,091,646 units of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. This award is part of a larger Indefinite Delivery...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4VP
    Delivery Order

This federal contract award, valued at $34,211.88, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product.

The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. As a prime vendor, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of Department of Defense (DoD) healthcare facilities and personnel.

This contract award does not have a set-aside designation, and it is expected to be completed by August 23, 2024.

Generated 11/1/24, 10:18 AM